Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits
Author:
Affiliation:
1. Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA
2. Department of Ophthalmology at University of Sao Paulo, Sao Paulo, Brazil
Publisher
Association for Research in Vision and Ophthalmology (ARVO)
Subject
Ophthalmology,Biomedical Engineering
Reference20 articles.
1. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism;Habashi;Science,2011
2. Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits;Sampaio;Exp Eye Res,2022
3. Topical losartan and corticosteroid additively inhibit corneal stromal myofibroblast generation and scarring fibrosis after alkali burn injury;Sampaio;Transl Vis Sci Technol,2022
4. Losartan inhibition of myofibroblast generation and late haze (scarring fibrosis) after PRK in rabbits;Sampaio;J Ref Surg,2022
5. Topical losartan for treating corneal fibrosis (haze): first clinical experience;Souza;J Ref Surg,2022
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of Topical Losartan in the Treatment of Established Corneal Fibrosis in Rabbits;Translational Vision Science & Technology;2024-08-12
2. Salzmann's Nodular Degeneration in Refractive Surgery: The Earlier Hit Hypothesis of EBM Injury-Related Fibrosis of the Subepithelial Space and Deeper Corneal Extension;Journal of Refractive Surgery;2024-05
3. Two-phase mechanism in the treatment of corneal stromal fibrosis with topical losartan;Experimental Eye Research;2024-05
4. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo;The Ocular Surface;2024-04
5. Regenerative Therapy for Corneal Scarring Disorders;Biomedicines;2024-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3